| Q4 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-03-16 | ||||||
| REV | |||||||
| Q3 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.080 | -0.150 | -0.0700 | ||||
| REV | 3.060M | 3.158M | 98.000K |
| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
You can purchase shares of ThermoGenesis Holdings (NASDAQ: THMO) through any online brokerage.
Other companies in ThermoGenesis Holdings’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Aethlon Medical (NASDAQ:AEMD), Motus GI Hldgs (NASDAQ:MOTS), Medigus (NASDAQ:MDGS) and Viveve Medical (NASDAQ:VIVE).
The latest price target for ThermoGenesis Holdings (NASDAQ: THMO) was reported by HC Wainwright & Co. on November 13, 2020. The analyst firm set a price target for 8.50 expecting THMO to rise to within 12 months (a possible 758.59% upside). 0 analyst firms have reported ratings in the last year.
The stock price for ThermoGenesis Holdings (NASDAQ: THMO) is $0.99 last updated Fri Jan 21 2022 20:57:23 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for ThermoGenesis Holdings.
ThermoGenesis Holdings’s $Q4 earnings are confirmed for after-market on March 16, 2022.
There is no upcoming split for ThermoGenesis Holdings.
ThermoGenesis Holdings is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.